止痛貼市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品類型、類型、配銷通路、地區和競爭細分，2020-2030F

2024 年全球止痛貼片市場價值為 51.2 億美元，預計到 2030 年將達到 67.8 億美元，預測期內複合年成長率為 4.76%。止痛貼已成為治療各種疼痛的方便有效的解決方案，為傳統口服藥物提供了替代方案。這些貼片透過經皮藥物傳遞系統提供局部緩解，使其成為尋求舒適和便利的疼痛管理患者的理想選擇。近年來，受慢性疼痛病症患病率不斷上升、人口老化以及對非侵入性疼痛管理解決方案的需求不斷成長等因素推動，全球止痛貼市場經歷了大幅成長。關節炎、背痛、神經性疼痛和纖維肌痛等慢性疼痛病症在全球呈上升趨勢。止痛貼片提供了一種針對性的方法來控制慢性疼痛，並且沒有口服藥物的副作用，因此很受歡迎。隨著全球人口老化，與年齡相關的疼痛狀況的發生率也越來越高。老年人通常更喜歡止痛貼，因為它們易於使用且能持續緩解疼痛，無需頻繁使用。止痛貼是非侵入性的，無需注射或服用藥丸，是一種控制疼痛的謹慎方法。這對尋求替代疼痛緩解方法的患者很有吸引力。藥物傳遞技術的持續研究和開發已帶來更有效率和更持久的止痛貼片型。這些貼片現在可以輸送多種藥物，包括鴉片類藥物、非類固醇抗發炎藥 (NSAID) 和肌肉鬆弛劑。製藥公司和醫療器材製造商正在不斷擴大其止痛貼產品組合。這包括開發針對特定疼痛類型的貼片，以及引入創新功能，例如根據患者需求監測和調整藥物傳遞的智慧貼片。

主要市場促進因素

慢性疼痛盛行率上升推動全球止痛貼市場發展

主要市場挑戰

定價和報銷

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球止痛貼市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品類型（非鴉片類貼片、鴉片類貼片）
  • 依類型（處方藥、非處方藥）
  • 按配銷通路（醫院藥房、藥局和零售藥房、線上供應商）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第 6 章：北美止痛貼市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第 7 章：歐洲止痛貼市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太地區止痛貼市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲止痛貼市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲止痛貼市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如果有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• NEXGEL Inc.
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Endo, Inc.
• Purdue Pharma LP
• Amneal Pharmaceuticals LLC
• Grunenthal GmbH

第 15 章：策略建議

第16章 關於出版商,免責事項

Global Pain Patch Market was valued at USD 5.12 Billion in 2024 and is expected to reach USD 6.78 Billion by 2030 with a CAGR of 4.76% during the forecast period. Pain patches have emerged as a convenient and effective solution for managing various forms of pain, offering an alternative to traditional oral medications. These patches deliver localized relief through transdermal drug delivery systems, making them an attractive option for individuals seeking comfort and convenience in pain management. The global pain patch market has experienced substantial growth in recent years, driven by factors such as the increasing prevalence of chronic pain conditions, an aging population, and a growing demand for non-invasive pain management solutions. Chronic pain conditions, such as arthritis, back pain, neuropathic pain, and fibromyalgia, are on the rise globally. Pain patches offer a targeted approach to manage chronic pain without the side effects associated with oral medications, contributing to their popularity. As the global population ages, there is a higher incidence of age-related pain conditions. Elderly individuals often prefer pain patches as they are easy to apply and provide sustained relief without the need for frequent dosing. Pain patches are non-invasive and offer a discreet way to manage pain without the need for injections or pills. This appeals to patients looking for alternative methods of pain relief. Ongoing research and development in drug delivery technologies have led to more efficient and long-lasting pain patch formulations. These patches can now deliver a variety of medications, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and muscle relaxants. Pharmaceutical companies and medical device manufacturers are continuously expanding their pain patch product portfolios. This includes the development of patches for specific pain types and the introduction of innovative features such as smart patches that monitor and adjust drug delivery based on the patient's needs.

Key Market Drivers

Rising Prevalence of Chronic Pain is Driving the Global Pain Patch Market

Chronic pain is a widespread and debilitating condition that affects millions of people worldwide, significantly impacting their quality of life. As the global population continues to age and the incidence of chronic conditions such as arthritis, back pain, and neuropathy rises, the demand for effective pain management solutions is on the rise. One such solution that is gaining traction in the healthcare industry is the pain patch. These transdermal patches are becoming increasingly popular due to their convenience, effectiveness, and ability to provide consistent pain relief. According to Centers for Disease Control and Prevention, in 2021, approximately 20.9% of U.S. adults, equating to 51.6 million people, reported experiencing chronic pain. Of these, 6.9% (17.1 million individuals) experienced high-impact chronic pain, which significantly restricts daily activities. The prevalence of chronic pain was notably higher among non-Hispanic American Indian or Alaska Native

Key Market Challenges

Pricing and Reimbursement

The pricing of pain patches is a major challenge in the healthcare market, particularly in regions where there is a strong emphasis on cost containment and budget restrictions within public and private healthcare systems. Manufacturers of pain patches must navigate complex pricing structures while attempting to keep their products affordable for a wide range of patients. Reimbursement policies from insurance companies significantly influence the accessibility of pain patches to patients. If insurance plans do not cover certain treatments or if the reimbursement rates are low, patients may be less likely to afford these products, thereby limiting market reach. Additionally, the negotiation process between manufacturers and insurers can affect the final pricing, potentially influencing the uptake of pain patches in both institutional and consumer markets. Therefore, manufacturers are tasked with balancing product quality and affordability, which requires ongoing adaptation to changing market dynamics and reimbursement structures.

Key Market Trends

Technological Advancements

The global healthcare industry is witnessing a significant transformation, driven by rapid technological advancements and a growing emphasis on patient-centric solutions. One notable area where these changes are manifesting is in the pain management sector. Traditional methods of pain relief, such as oral medications, injections, and physical therapy, are now being complemented and, in some cases, replaced by innovative solutions like pain patches. These patches are gaining traction in the global market due to their convenience, effectiveness, and advancements in their technology. In January 2021, Hisamitsu Pharmaceutical Co., Inc. declared that it had received approval for modifying certain aspects of the previously approved specifications for their new transdermal analgesic anti-inflammatory patches, known as "Mohrus Paps XR 120 mg and 240 mg." This adjustment aimed to alleviate the irritation caused by the current additives.

Key Market Players

• NEXGEL Inc.
• Viatris Inc.
• Johnson and Johnson
• Teva Pharmaceutical Industries Ltd.
• Sorrento Therapeutics Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• Endo, Inc.
• Purdue Pharma L.P.
• Amneal Pharmaceuticals LLC
• Grunenthal GmbH

Report Scope:

In this report, the Global Pain Patch Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pain Patch Market, By Product Type:

• Non-Opioid Patches
• Opioid Patches

Pain Patch Market, By Type:

• Prescription Medicines
• OTC Medicines

Pain Patch Market, By Distribution Channel:

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Providers

Pain Patch Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Pain Patch Market.

Available Customizations:

Global Pain Patch market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pain Patch Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Non-Opioid Patches, Opioid Patches)
  • 5.2.2. By Type (Prescription Medicines, OTC Medicines)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Pain Patch Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pain Patch Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Pain Patch Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Pain Patch Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Pain Patch Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pain Patch Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Pain Patch Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Italy Pain Patch Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. France Pain Patch Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Pain Patch Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Pain Patch Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pain Patch Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Pain Patch Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Pain Patch Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Pain Patch Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Pain Patch Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Pain Patch Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pain Patch Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Pain Patch Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Pain Patch Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Pain Patch Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pain Patch Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Pain Patch Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Pain Patch Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. NEXGEL Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Viatris Inc.
• 14.3. Johnson and Johnson
• 14.4. Teva Pharmaceutical Industries Ltd.
• 14.5. Sorrento Therapeutics Inc.
• 14.6. Hisamitsu Pharmaceutical Co., Inc.
• 14.7. Endo, Inc.
• 14.8. Purdue Pharma L.P.
• 14.9. Amneal Pharmaceuticals LLC
• 14.10. Grunenthal GmbH

15. Strategic Recommendations

16. About Us & Disclaimer